Protein tyrosine phosphatases are up-regulated and participate in cell death induced by polyglutamine expansion - PubMed

Affiliations

• PMID: 12226089
• DOI: 10.1074/jbc.M206890200

Free article

Protein tyrosine phosphatases are up-regulated and participate in cell death induced by polyglutamine expansion

Zhi-Liang Wu et al. J Biol Chem. 2002.

Free article

Abstract

Polyglutamine expansion is the cause of several neurodegenerative diseases. An in vitro model of polyglutamine-induced neuronal cell death was developed using truncated mutant huntingtin (Htt) and PC12 cells. Cell death was specifically observed in cells expressing a truncated mutant huntingtin-green fluorescence protein (GFP) fusion protein with 118 glutamine repeats (Gln(118)), as demonstrated by the release of lactate dehydrogenase (LDH). To gain further insights into the mechanisms of polyglutamine expansion-induced cell death, the Affymetrix rat genome array U34A was used to investigate gene expression changes associated with polyglutamine-mediated protein aggregation and cell death. Among the up-regulated genes, the increase of four protein tyrosine phosphatases (PTPs) was further confirmed by real-time quantitative reverse transcription PCR. Protein expression of mitogen activated protein (MAP) kinase phosphatase 1 (MKP1) was also increased as demonstrated by Western blot. Furthermore, phosphorylation of MAP kinase extracellular signal-regulated kinase 1/2 (ERK1/2) was substantially reduced in association with protein aggregation, and two general PTP inhibitors, sodium orthovanadate and bpV(pic), dramatically rescued the cells from polyglutamine-induced cell death. These results suggest that one or more of the PTPs are involved in the polyglutamine-induced cell death.

Similar articles

• Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.

  Wu W, Pew T, Zou M, Pang D, Conzen SD. Wu W, et al. J Biol Chem. 2005 Feb 11;280(6):4117-24. doi: 10.1074/jbc.M411200200. Epub 2004 Dec 7. J Biol Chem. 2005. PMID: 15590693

• Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin.

  Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo AP, Rubinsztein DC. Wyttenbach A, et al. Hum Mol Genet. 2002 May 1;11(9):1137-51. doi: 10.1093/hmg/11.9.1137. Hum Mol Genet. 2002. PMID: 11978772

• A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase.

  Blanco-Aparicio C, Torres J, Pulido R. Blanco-Aparicio C, et al. J Cell Biol. 1999 Dec 13;147(6):1129-36. doi: 10.1083/jcb.147.6.1129. J Cell Biol. 1999. PMID: 10601328 Free PMC article.

• Adaptor-tagged competitive PCR: study of the mammalian nervous system.

  Kato K. Kato K. C R Biol. 2003 Oct-Nov;326(10-11):941-7. doi: 10.1016/j.crvi.2003.09.013. C R Biol. 2003. PMID: 14750499 Review.

Cited by

• Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death.

  Park B, Oh CK, Choi WS, Chung IK, Youdim MB, Oh YJ. Park B, et al. J Neural Transm (Vienna). 2011 Nov;118(11):1585-98. doi: 10.1007/s00702-011-0710-x. Epub 2011 Sep 9. J Neural Transm (Vienna). 2011. PMID: 21904894

• Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis.

  Wyttenbach A. Wyttenbach A. J Mol Neurosci. 2004;23(1-2):69-96. doi: 10.1385/JMN:23:1-2:069. J Mol Neurosci. 2004. PMID: 15126694 Review.

• Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.

  Ginés S, Paoletti P, Alberch J. Ginés S, et al. J Biol Chem. 2010 Jul 9;285(28):21537-48. doi: 10.1074/jbc.M109.084202. Epub 2010 May 4. J Biol Chem. 2010. PMID: 20442398 Free PMC article.

• Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF.

  Puigdellívol M, Saavedra A, Pérez-Navarro E. Puigdellívol M, et al. Brain Pathol. 2016 Nov;26(6):752-771. doi: 10.1111/bpa.12432. Brain Pathol. 2016. PMID: 27529673 Free PMC article. Review.

• VGF and striatal cell damage in in vitro and in vivo models of Huntington's disease.

  Noda Y, Shimazawa M, Tanaka H, Tamura S, Inoue T, Tsuruma K, Hara H. Noda Y, et al. Pharmacol Res Perspect. 2015 Jun;3(3):e00140. doi: 10.1002/prp2.140. Epub 2015 May 4. Pharmacol Res Perspect. 2015. PMID: 26171223 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal